|
|
Volumn 374, Issue 3, 2016, Pages 296-297
|
|
Cytomegalovirus Retinitis in a Patient Who Received Ruxolitinib
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EYE DROPS;
GANCICLOVIR;
GLUCOCORTICOID;
MYDRIATIC AGENT;
RUXOLITINIB;
VALGANCICLOVIR;
JANUS KINASE;
PROTEIN KINASE INHIBITOR;
PYRAZOLE DERIVATIVE;
AGED;
AQUEOUS HUMOR;
CASE REPORT;
CYTOMEGALOVIRUS RETINITIS;
DEVICE FAILURE ANALYSIS;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG WITHDRAWAL;
EXTRAMEDULLARY HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
INFECTION CONTROL;
IRIDOCYCLITIS;
LETTER;
LOW DRUG DOSE;
MALE;
MEDICAL EXAMINATION;
MYELOID METAPLASIA;
OPHTHALMOLOGIST;
PAPILLEDEMA;
PRIORITY JOURNAL;
REAL TIME POLYMERASE CHAIN REACTION;
RETINA HEMORRHAGE;
SPLENOMEGALY;
VASCULITIS;
VISUAL ACUITY;
VITRITIS;
ANTAGONISTS AND INHIBITORS;
CHEMICALLY INDUCED;
CYTOMEGALOVIRUS;
ISOLATION AND PURIFICATION;
OPPORTUNISTIC INFECTION;
PRIMARY MYELOFIBROSIS;
AGED;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS RETINITIS;
HUMANS;
JANUS KINASES;
MALE;
OPPORTUNISTIC INFECTIONS;
PRIMARY MYELOFIBROSIS;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
|
|
EID: 84996487028
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1413918 Document Type: Letter |
|
Times cited : (36)
|
|
References (5)
|
